Methylphenidate reduces abnormalities of stimulus classification in adolescents with attention deficit disorder.


Forty-eight adolescents with attention deficit disorder (ADD) received placebo and methylphenidate (M = 35.21 mg/day) for 3 consecutive weeks each. ADD patients who received placebo in the first phase of treatment were compared with unmedicated normal adolescents. ADD and normal adolescents did not differ in slope of reaction time as a function of memory… (More)


  • Presentations referencing similar topics